Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials
Conclusion:
Escitalopram exhibited distinct advantages compared with other SSRIs, while Fluoxetine had the biggest cardiovascular reaction probability.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Cardiology | Cardiovascular | Celexa | China Health | Citalopram | Coronary Heart Disease | Databases & Libraries | Depression | Fluoxetine | Heart | Heart Disease | Internal Medicine | Lexapro | Paroxetine | Paxil | Prozac | Sertraline | Study | Zoloft